AZ announces US fast track designation for IL-5 inhibitor Fasenra
Designation granted for the treatment of eosinophilic gastritis with or without eosinophilic gastroenteritis
Read More
Tag: Food and Drug Administration
Valneva’s chikungunya virus vaccine granted breakthrough designation
Currently, no preventative vaccines or effective treatments are available for the chikungunya virus
Read More
Gilead’s Trodelvy scores accelerated approval in advanced bladder cancer
US Food and Drug Administration approved antibody drug conjugate based on Phase II trial results
Read More
US approval for first AI device to help detect colon cancer
Device designed to help clinicians detect lesions in the colon during a colonoscopy
Read More
FDA green light for Sarclisa combo in multiple myeloma
CD38 inhibitor approved in combination with carfilzomib and dexamethasone
Read More
FDA green light for BMS, bluebird bio’s CAR-T therapy Abecma in multiple myeloma
CAR-T therapy cleared for use in adults with relapsed or refractory multiple myeloma
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
